Quick Takeaways: Why It Matters? The Neion Bio–Barnwell Bio partnership highlights how environmental biosurveillance can strengthen biosecurity in biologics manufacturing, where flock health directly affects production continuity. By detecting facility-level pathoge...
Quick Takeaways: Why It Matters? Alveo Technologies and Royal GD are deepening a three‑year partnership (with 18 months of commercial use of their on‑farm avian influenza test) to co‑develop rapid molecular assays on the Alveo Sense platform for additional swine and cattle path...
Quick Takeaways: Why It Matters? ECO Animal Health’s acceptance of field safety data for Ecovaxxin MS by the USDA‑CVB is a key regulatory step toward US licensure of its Mycoplasma synoviae poultry vaccine, following the product’s EU commercial launch in July 2026. The large fi...
Cover Story Featured Article Product Launch Product Showcase Nestlé Invests CHF 157M to Expand Purina Pet Food Production Nestlé is investing more than CHF 157 million to expand its Purina pet food manufacturing site in Rayong, Thailand, increasing production capacity for pet food and trea...
Quick Takeaways: Why It Matters? Elanco’s $120M expansion of its Elwood, Kansas site quadruples monoclonal antibody capacity and adds upstream/downstream processing, a pilot plant and QC lab, directly supporting its new biologics franchise (Befrena&nbs...
Quick Takeaways: Why It Matters? The FDA’s Emergency Use Authorization for Simparica Trio to treat New World screwworm (NWS) larvae in dogs gives veterinarians a convenient, oral option that can be used alongside existing livestock tools (e.g., Dectomax...
Quick Takeaways: Why It Matters? ECO’s licence of Vaxinano’s late‑stage sheep toxoplasmosis vaccine gives it a low‑cost, de‑risked way to add a high‑value preventative product that directly tackles a major cause of abortion and lamb losses, with peak sales estimated a...
Quick Takeaways: Why It Matters? Boehringer Ingelheim’s purchase of Evax gives it a promising new way to treat common horse allergies with longer‑lasting vaccines instead of short‑term symptom relief, which could mean fewer vet visits and better outcomes for owners. If the approach works a...
Quick Takeaways: Why It Matters? The authorization expands Elanco’s screwworm portfolio beyond Negasunt Powder and Tanidil (earlier emergency tools) and complements EPA‑registered Catron IV, creating a more complete prevention-plus-treatment toolkit as USDA tracks dozens of animal cases an...
Quick Takeaways: Why It Matters? If the science holds up, this could open a future premium category for hypoallergenic dogs and related breeding or licensing programs, creating new value in the pet biotech space while also raising major regulatory, ethical, and animal-welfare h...
